Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer

Guang Yang, Alexei A. Goltsov, Chengzhen Ren, Shinji Kurosaka, Kohei Edamura, Richard Logothetis, Francesco J. DeMayo, Patricia Troncoso, Jorge Blando, John DiGiovanni, Timothy C. Thompson

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Previously we reported caveolin-1 (Cav-1) overexpression in prostate cancer cells and showed that it promotes prostate cancer progression. Here, we report that Cav-1 was overexpressed in 41.7% (15 of 36) of human highgrade prostatic intraepithelial neoplasia (HGPIN) specimens obtained during radical prostatectomies. Positive correlations exist between Cav-1-positive (Cav-1 +) HGPIN and Cav-1 + primary prostate cancer (rho = 0.655, P < 0.0001) and between Cav-1 and c-Myc expression in HGPIN (rho = 0.41, P = 0.032). To determine whether Cav-1 cooperates with c-Myc in development of premalignant lesions and prostate cancer in vivo, we generated transgenic mice with c-Myc overexpression driven by the ARR 2PB promoter. In this ARR 2PB-c-myc model, Cav-1 overexpression was found in mouse PIN (mPIN) lesions and prostate cancer cells and was associated with a significantly higher ratio of proliferative to apoptotic labeling in mPIN lesions than in the Cav-1-negative epithelia adjacent to those lesions (10.02 vs. 4.34; P = 0.007). Cav-1 overexpression was also associated with increased levels of P-Akt and VEGF-A, which were previously associated with Cav-1-induced prostate cancer cell survival and positive feedback regulation of cellular Cav-1 levels, respectively. In multiple prostate cancer cell lines, Cav-1 protein (but not mRNA) was induced by c-Myc transfection, whereas VEGF siRNA transfection abrogated c-Myc-induced Cav-1 overexpression, suggesting a c-Myc-VEGF-Cav-1 signaling axis. Overall, our results suggest that Cav-1 is associated with c-Myc in the development of HGPIN and prostate cancer. Furthermore, Cav-1 overexpression in HGPIN is potentially a biomarker for early identification of patients who tend to develop Cav-1 + primary prostate cancer.

Original languageEnglish
Pages (from-to)218-229
Number of pages12
JournalMolecular Cancer Research
Volume10
Issue number2
DOIs
Publication statusPublished - Feb 1 2012
Externally publishedYes

Fingerprint

Prostatic Intraepithelial Neoplasia
Caveolin 1
Prostatic Neoplasms
Up-Regulation
Vascular Endothelial Growth Factor A
Transfection
Caveolins

ASJC Scopus subject areas

  • Molecular Biology
  • Oncology
  • Cancer Research

Cite this

Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer. / Yang, Guang; Goltsov, Alexei A.; Ren, Chengzhen; Kurosaka, Shinji; Edamura, Kohei; Logothetis, Richard; DeMayo, Francesco J.; Troncoso, Patricia; Blando, Jorge; DiGiovanni, John; Thompson, Timothy C.

In: Molecular Cancer Research, Vol. 10, No. 2, 01.02.2012, p. 218-229.

Research output: Contribution to journalArticle

Yang, G, Goltsov, AA, Ren, C, Kurosaka, S, Edamura, K, Logothetis, R, DeMayo, FJ, Troncoso, P, Blando, J, DiGiovanni, J & Thompson, TC 2012, 'Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer', Molecular Cancer Research, vol. 10, no. 2, pp. 218-229. https://doi.org/10.1158/1541-7786.MCR-11-0451
Yang, Guang ; Goltsov, Alexei A. ; Ren, Chengzhen ; Kurosaka, Shinji ; Edamura, Kohei ; Logothetis, Richard ; DeMayo, Francesco J. ; Troncoso, Patricia ; Blando, Jorge ; DiGiovanni, John ; Thompson, Timothy C. / Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer. In: Molecular Cancer Research. 2012 ; Vol. 10, No. 2. pp. 218-229.
@article{cd69e4f03d5c41ac80a6f4e2b9f2f8ba,
title = "Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer",
abstract = "Previously we reported caveolin-1 (Cav-1) overexpression in prostate cancer cells and showed that it promotes prostate cancer progression. Here, we report that Cav-1 was overexpressed in 41.7{\%} (15 of 36) of human highgrade prostatic intraepithelial neoplasia (HGPIN) specimens obtained during radical prostatectomies. Positive correlations exist between Cav-1-positive (Cav-1 +) HGPIN and Cav-1 + primary prostate cancer (rho = 0.655, P < 0.0001) and between Cav-1 and c-Myc expression in HGPIN (rho = 0.41, P = 0.032). To determine whether Cav-1 cooperates with c-Myc in development of premalignant lesions and prostate cancer in vivo, we generated transgenic mice with c-Myc overexpression driven by the ARR 2PB promoter. In this ARR 2PB-c-myc model, Cav-1 overexpression was found in mouse PIN (mPIN) lesions and prostate cancer cells and was associated with a significantly higher ratio of proliferative to apoptotic labeling in mPIN lesions than in the Cav-1-negative epithelia adjacent to those lesions (10.02 vs. 4.34; P = 0.007). Cav-1 overexpression was also associated with increased levels of P-Akt and VEGF-A, which were previously associated with Cav-1-induced prostate cancer cell survival and positive feedback regulation of cellular Cav-1 levels, respectively. In multiple prostate cancer cell lines, Cav-1 protein (but not mRNA) was induced by c-Myc transfection, whereas VEGF siRNA transfection abrogated c-Myc-induced Cav-1 overexpression, suggesting a c-Myc-VEGF-Cav-1 signaling axis. Overall, our results suggest that Cav-1 is associated with c-Myc in the development of HGPIN and prostate cancer. Furthermore, Cav-1 overexpression in HGPIN is potentially a biomarker for early identification of patients who tend to develop Cav-1 + primary prostate cancer.",
author = "Guang Yang and Goltsov, {Alexei A.} and Chengzhen Ren and Shinji Kurosaka and Kohei Edamura and Richard Logothetis and DeMayo, {Francesco J.} and Patricia Troncoso and Jorge Blando and John DiGiovanni and Thompson, {Timothy C.}",
year = "2012",
month = "2",
day = "1",
doi = "10.1158/1541-7786.MCR-11-0451",
language = "English",
volume = "10",
pages = "218--229",
journal = "Molecular Cancer Research",
issn = "1541-7786",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

TY - JOUR

T1 - Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer

AU - Yang, Guang

AU - Goltsov, Alexei A.

AU - Ren, Chengzhen

AU - Kurosaka, Shinji

AU - Edamura, Kohei

AU - Logothetis, Richard

AU - DeMayo, Francesco J.

AU - Troncoso, Patricia

AU - Blando, Jorge

AU - DiGiovanni, John

AU - Thompson, Timothy C.

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Previously we reported caveolin-1 (Cav-1) overexpression in prostate cancer cells and showed that it promotes prostate cancer progression. Here, we report that Cav-1 was overexpressed in 41.7% (15 of 36) of human highgrade prostatic intraepithelial neoplasia (HGPIN) specimens obtained during radical prostatectomies. Positive correlations exist between Cav-1-positive (Cav-1 +) HGPIN and Cav-1 + primary prostate cancer (rho = 0.655, P < 0.0001) and between Cav-1 and c-Myc expression in HGPIN (rho = 0.41, P = 0.032). To determine whether Cav-1 cooperates with c-Myc in development of premalignant lesions and prostate cancer in vivo, we generated transgenic mice with c-Myc overexpression driven by the ARR 2PB promoter. In this ARR 2PB-c-myc model, Cav-1 overexpression was found in mouse PIN (mPIN) lesions and prostate cancer cells and was associated with a significantly higher ratio of proliferative to apoptotic labeling in mPIN lesions than in the Cav-1-negative epithelia adjacent to those lesions (10.02 vs. 4.34; P = 0.007). Cav-1 overexpression was also associated with increased levels of P-Akt and VEGF-A, which were previously associated with Cav-1-induced prostate cancer cell survival and positive feedback regulation of cellular Cav-1 levels, respectively. In multiple prostate cancer cell lines, Cav-1 protein (but not mRNA) was induced by c-Myc transfection, whereas VEGF siRNA transfection abrogated c-Myc-induced Cav-1 overexpression, suggesting a c-Myc-VEGF-Cav-1 signaling axis. Overall, our results suggest that Cav-1 is associated with c-Myc in the development of HGPIN and prostate cancer. Furthermore, Cav-1 overexpression in HGPIN is potentially a biomarker for early identification of patients who tend to develop Cav-1 + primary prostate cancer.

AB - Previously we reported caveolin-1 (Cav-1) overexpression in prostate cancer cells and showed that it promotes prostate cancer progression. Here, we report that Cav-1 was overexpressed in 41.7% (15 of 36) of human highgrade prostatic intraepithelial neoplasia (HGPIN) specimens obtained during radical prostatectomies. Positive correlations exist between Cav-1-positive (Cav-1 +) HGPIN and Cav-1 + primary prostate cancer (rho = 0.655, P < 0.0001) and between Cav-1 and c-Myc expression in HGPIN (rho = 0.41, P = 0.032). To determine whether Cav-1 cooperates with c-Myc in development of premalignant lesions and prostate cancer in vivo, we generated transgenic mice with c-Myc overexpression driven by the ARR 2PB promoter. In this ARR 2PB-c-myc model, Cav-1 overexpression was found in mouse PIN (mPIN) lesions and prostate cancer cells and was associated with a significantly higher ratio of proliferative to apoptotic labeling in mPIN lesions than in the Cav-1-negative epithelia adjacent to those lesions (10.02 vs. 4.34; P = 0.007). Cav-1 overexpression was also associated with increased levels of P-Akt and VEGF-A, which were previously associated with Cav-1-induced prostate cancer cell survival and positive feedback regulation of cellular Cav-1 levels, respectively. In multiple prostate cancer cell lines, Cav-1 protein (but not mRNA) was induced by c-Myc transfection, whereas VEGF siRNA transfection abrogated c-Myc-induced Cav-1 overexpression, suggesting a c-Myc-VEGF-Cav-1 signaling axis. Overall, our results suggest that Cav-1 is associated with c-Myc in the development of HGPIN and prostate cancer. Furthermore, Cav-1 overexpression in HGPIN is potentially a biomarker for early identification of patients who tend to develop Cav-1 + primary prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=84857224992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857224992&partnerID=8YFLogxK

U2 - 10.1158/1541-7786.MCR-11-0451

DO - 10.1158/1541-7786.MCR-11-0451

M3 - Article

VL - 10

SP - 218

EP - 229

JO - Molecular Cancer Research

JF - Molecular Cancer Research

SN - 1541-7786

IS - 2

ER -